Clinion
Bangalore, India· Est.
AI‑powered eClinical platform that streamlines and automates every phase of clinical trials for sponsors and CROs.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑powered eClinical platform that streamlines and automates every phase of clinical trials for sponsors and CROs.
OncologyCardiologyInfectious DiseasesVaccinesNeurology
Technology Platform
A cloud‑native, AI‑enhanced eClinical suite that integrates protocol generation, EDC, CTMS, RTSM, eConsent, ePRO, eSource and AI‑driven data analytics on a single modular platform.
Opportunities
Expansion into decentralized trial markets and deeper AI integration can drive new client acquisition and higher per‑study pricing.
Risk Factors
Intense competition from established eClinical vendors and the need to continuously meet evolving global regulatory standards pose significant risks.
Competitive Landscape
Clinion competes with Medidata, Veeva, Oracle and smaller niche AI eClinical startups, differentiating itself through end‑to‑end AI automation and a unified modular architecture.